Belgium· BE-AMP-SAM662393-00

Bosutinib EG 100 mg

A bosutinib product containing bosutinib, registered in Belgium by EG. The same ATC class is registered in 15 of our 19 countries.

ATC L01EA04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about bosutinibAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Bosutinib is registered in 15 of 19 countries.

Countries holding a registration under ATC L01EA04 (bosutinib), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search bosutinib products by name

Bosutinib · ATC L01EA04

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bosutinib costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Bosutinib · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$65.58

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Bosutinib
Manufacturer: EG
Country: Belgium (BE)
ATC code: L01EA04
ATC class: Bosutinib
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
7741242
be_apb
4862017

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

469 interactions on record for bosutinib.

Graded by severity as the source publishes them — 159 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check bosutinib against other medicines How interaction checks work

Bosutinib · interactions on record

469 records

159 severe
307 moderate
3 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
AprepitantA04AD12severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bosutinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bosutinib products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Bosutinib Sandoz, Bosutinib Teva
Bulgaria · Босутиниб Msn, Босутиниб Зентива
Czechia · Bosutinib Msn, Bosutinib Teva
Germany · Bosutinib, Bosutinib Al
Denmark · Bosutinib Newbury, Bosutinib Sandoz
Estonia · Bosutinib Msn
Spain · Bosutinib, Bosutinib Vivanta
Finland · Bosutinib Stada
France · Bosutinib Biogaran, Bosutinib Eg Labo
United Kingdom (Northern Ireland) · Bosutinib Dr. Reddy’s, Bosutinib Stada
Croatia · Bosutinib Msn, Bosutinib Onkogen
Hungary · Bosutinib Onkogen, Bosutinib Sandoz
Ireland · Bosutinib Clonmel, Bosutinib Rowex
Iceland · Bosulif, Bosutinib Beta
Italy · Bosutinib Dr. Reddys, Bosutinib Eg
Liechtenstein · Bosulif
Lithuania · Bosutinib Msn
Luxembourg · Bosutinib Eg
Latvia · Bosutinib Msn
Malta · Bosutinib, Bosutinib Lotus
Netherlands · Bosutinib, Bosutinib Cf
Norway · Bosulif, Bosutinib Newbury
Poland · Bosutinib Msn, Bosutinib Onkogen
Portugal · Bosutinib Teva
Romania · Bosutinib Teva
Sweden · Bosutinib Newbury, Bosutinib Sandoz
Slovenia · Bosutinib Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4ecd2a95-8e71-4dd3-990d-fe49c0ab096c
GET /v1/drugs/4ecd2a95-8e71-4dd3-990d-fe49c0ab096c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Bosutinib EG 100 mg",
  "name_fr": "Bosutinib EG 100 mg",
  "name_nl": "Bosutinib EG 100 mg",
  "amp_code": "SAM662393-00",
  "strengths": [
    "100.0000",
    "100.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Bosutinib"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Bosutinib",
  "authorisation_numbers": [
    "BE662393"
  ]
}

API reference MCP server Plans

See everything about bosutinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console